The IPVS Policy Committee participates in the development and maintenance of position statements on issues related to papillomaviruses and the development of prevention of their associated diseases. The Committee also comments on new scientific, clinical and policy developments and develop educational professional and public information services, as needed, on behalf of IPVS.

Please find below the policy statements of the IPVS Policy Committee.

Title Link
COVID-19 as a catalyst for reimagining cervical cancer prevention Link
HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues Link
Equity in cervical cancer prevention: for all and not just for some View PDF
IPVS Policy Statement addressing the burden of HPV disease for Indigenous people View PDF
HPV prevention and control – The way forward Link
IPVS Statement on Temporary HPV vaccine shortage: Implications globally to achieve equity View PDF
Moving towards Elimination of Cervical Cancer as a Public Health Problem View PDF
HPV vaccination of immunocompromised hosts View PDF
IPVS Statement on HPV vaccination and immunocompromised hosts April 2017 View PDF
The Cape Town Declaration on the Prevention of Human Papillomavirus Disease View PDF
IPVS policy vaccine safety statement September 2015 View PDF